Although the mechanism has not been completely discovered yet, it is suggested that the high proportion of NKG2C−/NKG2A+ cells in patients with COVID-19 is associated with higher HCMV viremia and mortality [169, 170]. This evidence concerns the gene KLRC2 and COVID-19.